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Abstract
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Objectives—To describe unique features of neurocritical illness that are relevant to provision of
high-quality palliative care; To discuss key prognostic aids and their limitations for neurocritical
illnesses; To review challenges and strategies for establishing realistic goals of care for patients in
the neuro-ICU; To describe elements of best practice concerning symptom management,
limitation of life support, and organ donation for the neurocritically ill.
Data Sources—A search of Pubmed and MEDLINE was conducted from inception through
January 2015 for all English-language articles using the term “palliative care,” “supportive care,”
“end-of-life care,” “withdrawal of life-sustaining therapy,” “limitation of life support,”
“prognosis,” or “goals of care” together with “neurocritical care,” “neurointensive care,”
“neurological,” “stroke,” “subarachnoid hemorrhage,” “intracerebral hemorrhage,” or “brain
injury.”

Author Manuscript

Data Extraction and Synthesis—We reviewed the existing literature on delivery of palliative
care in the neurointensive care unit setting, focusing on challenges and strategies for establishing
realistic and appropriate goals of care, symptom management, organ donation, and other
considerations related to use and limitation of life-sustaining therapies for neurocritically ill
patients. Based on review of these articles and the experiences of our interdisciplinary/
interprofessional expert Advisory Board, this report was prepared to guide critical care staff,
palliative care specialists, and others who practice in this setting.
Conclusions—Most neurocritically ill patients and their families face the sudden onset of
devastating cognitive and functional changes that challenge clinicians to provide patient-centered
palliative care within a complex and often uncertain prognostic environment. Application of
palliative care principles concerning symptom relief, goal setting, and family emotional support,
will provide clinicians a framework to address decision-making at a time of crisis that enhances
patient/family autonomy and clinician professionalism.
Keywords

Author Manuscript

neurocritical care; neuro ICU; intensive care unit; palliative care; end of life care

Introduction
Neurocritical illness, defined as critical illness primarily involving the brain, spinal cord, or
neuromuscular system [1], is often a sudden, catastrophic event for patients and their
families. Although advances in neurocritical care continue to improve outcomes, mortality
rates for common conditions including intracerebral hemorrhage and anoxic brain injury
Crit Care Med. Author manuscript; available in PMC 2016 September 01.

Frontera et al.

Page 3

Author Manuscript

range above 50%, and many patients never regain functional independence (Table 1).
Patients often experience significant cognitive loss along with deterioration in quality of life.
[2, 3] Even for those who survive without permanent disabilities, recovery from
neurological injury can be prolonged and accompanied by physical and psychological
distress for patients as well as practical and emotional burdens for families. For these
reasons, palliative care, including communication about goals of care in relation to the
patient's condition, prognosis, and preferences, is an important component of high quality
care in the neurocritical care environment.

Author Manuscript

Palliative care focuses on relief of symptoms, effective communication about goals of care,
alignment of treatment with patient preferences, family support, and planning for transitions.
[4, 5] Whereas hospice or end of life care is for patients approaching death, palliative care is
appropriate in the context of any serious illness, regardless of stage or prognosis, and is
optimally provided together with, not in lieu of, disease-directed or life-prolonging
treatment. Palliative care is an interprofessional specialty, but also an approach for all
clinicians caring for seriously ill patients who are expected to provide excellent “generalist”level palliative care.[6]
In this article, The IPAL-ICU (Improving Palliative Care in the ICU) Project Advisory
Board brings interdisciplinary and interprofessional expertise together to address challenges
and strategies regarding prognostication, communication, and decision making for the
neurocritical care patient and family.
Onset and Trajectory of Neurocritical Illness

Author Manuscript

The onset of neurocritical illness is usually abrupt and follows a trajectory that is distinct
from that of other patients with life-threatening illness (Figure 1).[7, 8] Neurocritically ill
patients often face a sudden and total transformation from good health and independence to
the prospect of death or serious and permanent disability. Over 70% of patients in the neuroICU have no premorbid symptoms and present with a precipitous loss of physical and
cognitive function.[9, 10] Therefore, from the onset, clinicians face the challenge of helping
families cope with the impact of an unexpected and devastating illness, making it more
difficult to focus on the decision-making process.

Author Manuscript

Decision-making is further complicated by the unpredictable and extended course of many
forms of neurocritical illness. Often, patients do not progress to death (by cardiovascular or
brain-based criteria) after neurological injury, but instead either improve slowly over several
months or stagnate in a severely disabled state. Most deaths among the neurocritically ill
occur after limitation of life-sustaining therapies. Nationally, 13.5% -15% of patients in
neuro-ICUs have life-sustaining therapies withheld or withdrawn, and limitation of such
therapies precedes up to 61% of all deaths in the neuro-ICU.[9-11] In those who do not die,
recovery is prolonged. Brain-injured patients make their maximal spontaneous recovery over
3-6 months, though improvement can continue over the ensuing months with aggressive
rehabilitation.[12-15] Therefore, neurological changes that would affect decision-making
often occur well after the ICU and hospital stay, necessitating the use of prognostic scales
that can assist in early discussions about goals of care.

Crit Care Med. Author manuscript; available in PMC 2016 September 01.
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Prognosis: Tools and Limitations
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For some forms of neurocritical illness, specific clinical and radiographic features are
predictive of poor neurological outcome across a number of studies (Table 2).[16] However,
these predictors were derived primarily from observational studies, refer to a variety of time
frames as outcomes, and have other limitations as outlined below. In general, the loss of
brainstem reflexes, with radiographic confirmation of destruction of the brainstem or diffuse
cortical infarction, is incompatible with meaningful functional recovery. Though survival is
possible, the anticipated quality of life is often deemed unacceptable. In circumstances
where the prognosis is less certain, it is important for clinicians to know the strengths and
weaknesses of existing outcome data and prognostic models. Addressing uncertainty is an
important part of communicating with patients and families to establish realistic goals of
care.

Author Manuscript
Author Manuscript

A variety of prognostic scales offer useful outcome estimates for common neuro-ICU
conditions (Table 3). The Glasgow Coma Scale [17] was developed for patients with
traumatic brain injury (TBI). This scale (assessing eye opening, motor response, and verbal
response, with lower scores reflecting more severe injury) is often used for serial
abbreviated neurological exams and provides a globally recognized standard in neurological
assessment. The GCS is a highly reliable predictor of in-hospital mortality, but has limited
use for predicting long-term functional outcome of survivors. This scale has been applied
across a wider spectrum of neurological diagnoses, including intracranial hemorrhage.[18]
The NIH Stroke Scale is one of the most reliable instruments to predict outcome after
ischemic stroke.[19] In North America, the Hunt-Hess Grade [20] for subarachnoid
hemorrhage (SAH) is highly correlated with mortality and functional outcome. The
Intracerebral Hemorrhage (ICH) [18] and FUNC [21] scores are used to predict mortality
and functional outcomes, respectively, after intracerebral hemorrhage. These scales were
developed to estimate the most likely outcome, though application on an individual level is
more complex.

Author Manuscript

Impact of withdrawing life-sustaining treatment—Most studies describing the
outcome of patients with severe brain injury have included patients from whom lifesustaining therapy was withheld or withdrawn. Yet, studies of ICH, SAH and TBI patients
have found that an early “do not attempt resuscitation” (DNAR or DNR) directive and/or
withdrawal of life-sustaining treatment as much as doubled the short- and long-term
mortality, even after adjusting for known predictors of mortality (age, gender, ethnicity,
Glasgow Coma Scale, ICH volume, intraventricular hemorrhage and infratentorial
hemorrhage).[22-26] Thus, reliance on existing mortality data for prognostication can give
rise to a “self-fulfilling prophecy” and perpetuate high mortality rates. Inclusion of patients
undergoing early limitation of life support can confound the development of new prognostic
models and hamper clinical trials to develop life-saving interventions for neurocritically ill
patients. However, it is ethically important to offer families the option of withdrawal of lifesupport in keeping with the patient's right to autonomy and right to make an informed
decision. A possible approach to this conundrum would be to use functional outcomes rather
than mortality as primary endpoints. The development of new technologies and
methodologies to predict outcome [27] after neurological injury is essential to improving the
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design of clinical trials and strengthening the ability of clinicians and families to make
informed decisions about appropriate goals of care.

Author Manuscript
Author Manuscript

Model Characteristics—Models that predict functional outcome and quality of life,
rather than mortality alone, would be more valuable for both clinicians and families.
However, existing functional outcome scores (such as the Glasgow Outcome Score [28] or
the modified Rankin Score [29, 30]) are heavily weighted toward motor ability and do not
take into account other important outcomes such as cognitive and emotional function and
quality of life, which are of utmost importance to patients and families.[31, 32] Prediction
models for quality of life after neurocritical care have not been robustly developed, and
proxy assessment tools to measure quality of life are scant and not well validated. Many
studies use dichotomized outcomes, with arbitrary and varying cut-points that may not be
meaningful for patients and their families. For example, the modified Rankin Scale (mRS)
[29, 30], which ranges from 0 (no symptoms) to 6 (death), is variably dichotomized as 0-3
(0=no symptoms, 3=moderate disability requiring some help but able to walk without
assistance) versus 4-6 (4=moderately severe disability; unable to walk without assistance or
attend to bodily needs, 6=death), or as 0-1 (0=no symptoms, 1=no significant disability
despite symptoms) versus 2-6 (2=slight disability but able to carry out own affairs, 6=death).
Depending on the cut-point used, study results may significantly differ. In addition, trials
yielding data used to generate prognostic scales often exclude the most severely affected
patients, for whom little data are then available regarding the impact of treatments. Finally,
models used for prognostication project what happens to a population on average; they
cannot predict the outcome of any given individual. Adjustment for case-mix and the use of
patient or family-reported outcomes in future studies may help improve prognostication, but,
importantly, such models will always suffer from this inherent limitation.[33, 34] Models
that predict functional recovery are also limited by the challenges in predicting an individual
patient's ability to adapt (“response shift”) to a neurologic deficit that the patient has not yet
experienced, as well as reframing or changing perceptions of quality of life that can occur
over time.[35, 36]
Models Based on Outdated Practice or Lacking Adequate Validation—Older
prognostication tools may reflect outdated medical and surgical practices that have evolved
to offer patients a chance of better neurological recovery.[37] In addition, certain commonly
used scales have not been validated or rigorously tested in different cohorts.[38]

Author Manuscript

Practitioner Variability—Survey results suggest that many physicians are both overly
pessimistic and inaccurate in predicting outcome, particularly within the first 72 hours of
neurocritical illness.[22, 39] There is also significant variation in physician perception of
prognosis in case-based scenarios.[40] In addition, early medical and surgical interventions
in many neurocritical illnesses can substantially alter a patient's clinical course. In
recognition of these and other factors, the American Heart Association together with the
American Stroke Association recommends that new DNR orders be deferred and full
intensive care therapy be administered after ICH at least until the second day of
hospitalization.[41] An initial trial of full intensive care therapy is also generally appropriate
for the first 24-72 hours in other types of neurocritical illness, unless the patient has a
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condition outlined in Table 2 or clearly expressed a different preference through advance
care planning. A longer period of observation would be appropriate when functional
recovery is particularly difficult to predict and may continue over weeks to months, as for a
young patient with traumatic brain injury.
Conversely, some physicians are overly optimistic when discussing prognosis with patients
and families.[42] The motivation for this optimism may be to maintain hope for recovery,
and/or avoid emotionally-laden encounters with patients or surrogates. Physicians also
experience feelings of professional failure that make it difficult to acknowledge that the
patient faces almost certain death or devastating neurologic impairment.[43] Although hope
may help patients and surrogates cope with a serious illness, false hope tends to undermine
the clinician-patient relationship, as well as delay appropriate decision-making.[44]

Author Manuscript

Public perceptions of recovery

Author Manuscript

Patients’ and families’ perceptions of neurocritical illness may be influenced by portrayals
in film and other media that distort the reality of coma, persistent vegetative state, or
minimally conscious state and tend to exaggerate the recovery prospects. In a review of 30
movies between 1970 and 2004, only two were found to represent coma realistically and
60% of coma patients portrayed in films awoke suddenly, even after a prolonged period of
time, with intact cognition and physical function.[45] Although 15-50% of patients with
persistent vegetative state regain consciousness over one year, depending on the mechanism
of injury, the majority of these patients remain moderately-severely disabled and only 7%
make a functional recovery, defined as mobile, able to communicate, and perform activities
of daily living.[46, 47] Overall, the life expectancy for patients in persistent vegetative state
is 2-5 years.[48] Patients with minimally conscious state (defined by intermittent command
following and/or some ability to interact with their environment) have better long term
outcomes than those with persistent vegetative state, but still, most remain disabled and
dependent.[49] “Medically-induced coma” has a very different prognosis for recovery than
coma resulting from illness or injury, but this distinction is frequently blurred in the media
and poorly understood by the public.[50] To address potential misperceptions, clinicians
need to explore the family's understanding of the nature and likely outcomes of the patient's
condition, focus on the unique clinical circumstances, and endeavor to bring the family's
perceptions and expectations into closer alignment with medical realities. A public
education effort addressing the realities of brain injury is needed.
Strategies for establishing goals of care

Author Manuscript

Integrating the Interdisciplinary, Interprofessional Team—The expertise of a
variety of clinicians can contribute to optimal care. We recommend that the clinical team
(including intensivists, neurologists, and neurosurgeons) huddle at each critical discussion
juncture to present a common message to the family, particularly when presenting prognosis
and the uncertainty surrounding it. Physical therapists and neuro-rehabilitation specialists
may be able to provide specific insight into expected long-term disabilities and the recovery
process. Specialists in palliative care can support both the primary team and the family to
address difficult decisions and complex symptoms. Ideally, involvement of such specialists
is not deferred until the patient is imminently dying, since they are most effective when
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engaged early enough to build a trusting relationship with the family. At the same time,
basic, generalist-level palliative care, remains the responsibility of the primary team, and
should be part of daily practice. Both “specialist” and “generalist” models of palliative care
are effective and a combined approach may represent the optimal model.[51, 52]. Strategies
for developing such models have been reviewed.[52] ICU staff can be trained to manage
distressing symptoms and conduct interprofessional/interdisciplinary family meetings, while
involvement of palliative care specialists can support the primary team, particularly in the
most challenging situations, and provide continuity of care to the patient and family.[52]
Bedside ICU nurses can offer significant contributions to communication about appropriate
and realistic goals of care, especially when physician-nurse communication has been
optimized.[53] Social work, psychology, ethics services, pastoral care, and case
management services all have a role to play in helping families.

Author Manuscript

Timing of Goals of Care Discussions—Effective communication with patients and
families balances honesty with empathy and hope [54], and proceeds in the context of the
condition and prognosis as well as the values, goals and preferences of the patient.[55] From
the time of admission, available prognostic information, and all indicated treatment options
should be openly discussed, along with a review of prior advance care planning so that the
patient's wishes are respected. For patients without an advance directive, it is reasonable to
initiate a time-limited trial of full intensive care therapy, except in extreme circumstances
(e.g., brain death, poor premorbid function, low probability of successful intervention, and
factors listed in Table 2). Early intervention may directly alter the patient's prognosis.

Author Manuscript

Shared, value-based, decision-making—The patient's values, goals and preferences
provide the touchstone for communication and decision-making. Whether or not the patient
specifically articulated such wishes, shared decision-making about appropriate goals of care
entails discussion of the patient's values, including the quality of life that the patient would
find acceptable. Especially in the context of neurocritical illness, in which patients may
survive but with significant loss of function and cognition, the scope of discussion between
clinicians and families must extend beyond a patient's chances for survival, to a fuller
conversation about achievable goals in relation to the patient's condition, prognosis, and
values. In these discussions the focus must remain on the values of the patient, rather than
concerns of the family, or views projected by the clinician. Table 4 outlines an approach that
facilitates discussion of a patient's values as the basis for decision-making.[55] Putting the
physician's prognostic estimate of neurological outcome together with the patient's goals and
values allows for a process of shared decision-making to develop a plan of care (Figure 2).

Author Manuscript

Communicating Prognosis—When offering an estimated prognosis for neurological
function, it can be helpful to communicate concrete skills, including activities of daily
living, which the patient may or may not have a reasonable chance of achieving. For
example, “the most likely outcome, should full, aggressive life support be applied, is that the
patient will be completely dependent for all basic activities such as bathing, dressing and
toileting, and likely require a machine to breathe, a feeding tube, and placement in a nursing
home.” Or, “the patient will be weak on one side, and unable to walk, but still able to
communicate and interact meaningfully with loved ones.” It is important to describe not
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only potential deficits, but also skills that the patient is likely to retain, since certain deficits
may be acceptable based on the patient's values or prior expressed wishes.
Families often inquire about signs of neurological improvement that may alter prognosis. In
general, for comatose patients, saccading (quick movements of both eyes in the same
direction) to voice, tracking, and command-following are signs of improvement. One
commonly misinterpreted interaction with the comatose patient is the grasp reflex. Since
primitive reflexes can reemerge in the comatose state, families may believe that the patient
is squeezing a loved one's hand purposefully. Careful explanation of reflexive movements is
important for addressing family expectations, with recognition that the family may continue
to interpret patients’ movements differently.[56]

Author Manuscript

Addressing Prognostic Limitations—The limitations of current prognostic models
should not preclude clinicians from sharing an opinion on the patient's potential outcome.
Communication that acknowledges the uncertainty of outcome predictions can actually build
trust and is consistent with a shared-decision model of patient-clinician communication and
with empirical data about patients’ and families’ interest in prognostic information, even if
there is uncertainty.[57] In addition, communication can acknowledge that prognosis is not
based on the admission neurological assessment alone, but may be altered by early treatment
decisions, such as a decision to proceed with surgery. Besides consideration of diseasespecific prognosis, clinicians should account for individual patient factors such as age,
premorbid functional status, medical comorbidities and admission neurological and
physiological status that interact to affect prognosis (Figure 2).[58] Some studies suggest
that the combination of model-based prediction with expert clinician outcome estimates may
be superior to either approach alone.[59]

Author Manuscript

Addressing family guilt—Surrogates may feel guilt, doubt, and regret about their
decisions, especially when the patient was healthy prior to a sudden neurological
catastrophe. Many surrogates carry these negative emotions for months to years.[60] To
address and attempt to alleviate such distress, discussions may be framed in terms of the
obligation to respect the patient's wishes, and the opportunity to help the patient preserve
dignity when death is inevitable.[61] Intensive care support may only prolong the dying
process, causing more suffering with the same eventual result.

Author Manuscript

Presenting Goals of Care Options—Communication about goals of care may be most
effective when discussions are iterative, with continued discussion that takes account of the
evolving clinical situation. Clear pathways of care, i.e., full life support including
tracheotomy and feeding tube placement versus care focused exclusively on comfort (often
referred to as “comfort measures only”), are the two most typical treatment approaches for
neurocritically ill patients. Although some physicians may offer partial treatment options
rather than directly addressing realistic goals of care, this approach can confuse the family,
and partial treatment plans can lead to the same outcome as a “comfort measures only”
approach, but with prolongation of the dying process and preventable distress. A timelimited trial of full intensive care with observation for improvement may be helpful when
the outcome is unclear.[62] The use of approaches such as “no escalation of treatment,”
which is another form of partial treatment, is more controversial.[63, 64] Families should be
Crit Care Med. Author manuscript; available in PMC 2016 September 01.
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given adequate time to consider and modify goals of care, and to place increasing emphasis
on palliative care at any stage in the patient's course.
Considerations in Withdrawal of Life-Sustaining Therapies

Author Manuscript

Symptom Management During Withdrawal of Life Support—The withdrawal of
life-sustaining therapies should follow a written protocol to ensure attention to all key
elements, including documentation of the goals of care and the resuscitation status.[65, 66]
Consideration to family and visitor needs should be given when determining the timing of
life support withdrawal. Although stroke and other neurocritically ill patients tend to have a
lower symptom burden than other seriously ill patients,[67] pain, discomfort, and anxiety
may cause distress even for a brain-injured patient. Patients with spinal cord injury, terminal
neuromuscular disease, stroke, brain tumor, and other conditions may also suffer from thirst,
dyspnea, fatigue, sleep deprivation, incontinence, depression, anxiety, delirium and
emotional lability.[68] Because neuroICU patients are often unable to communicate their
needs, clinicians must be especially vigilant for signs of discomfort.[69] Tachycardia and
tachypnea may be the only manifestations of distress, although they are non-specific.
Treatment of these symptoms in patients with neurocritical illness is similar to that in the
general critical care population.[69]

Author Manuscript

Preparation for withdrawal of life-sustaining therapy includes having opioids available at the
bedside prior to extubation to manage agonal breathing patterns and other signs of air
hunger or distress. Anticholinergics (e.g., glycopyrrolate) can reduce tracheobronchial
sections, and gurgling (death rattle) for some patients, although no large-scale, placebocontrolled study has been conducted to confirm this effect,[70] and death rattle may not be
correlated with patient respiratory distress.[71] Anxiolytics and other sedatives should be
immediately available to treat agitation or anxiety. Some ICUs use specific titration goals,
such as increasing the dose of opioids and/or sedatives to maintain a heart rate less than 100
beats per minute or respiratory rate less than 20 breaths per minute. Such guidelines offer
concrete guidance for nursing staff and may help prevent under-treatment of dyspnea and
agitation.
Medications and interventions that do not offer symptom relief should be discontinued,
including antibiotics, vasopressors/inotropes, antithrombotics, intravenous hydration,
artificial feeding and patient monitors. Anti-epileptic medications may be continued since a
seizure is considered to be an uncomfortable complication.

Author Manuscript

Long-acting sedatives—It is unnecessary to wait for a washout of long-acting sedative
medications (e.g., barbiturates) prior to withdrawal of life-sustaining therapy. A prolonged
delay to withdrawal in this context can be emotionally difficult for families and staff. The
concept of autonomy supports a patient's ability to limit life support measures at any time,
even if there is residual medication effect.[72] Withdrawal in the context of long-acting
sedatives is not causing death, but is “allowing the patient to die” from the underlying
illness.[73, 74] In addition, the “principle of double effect” supports the use of a therapy that
is intended to provide symptom relief (such as pentobarbital and other long-acting sedatives

Crit Care Med. Author manuscript; available in PMC 2016 September 01.

Frontera et al.

Page 10

Author Manuscript

for delirium or sleep disruption at end of life),[75-80] even if death is hastened as a
secondary effect of the therapy.[81]

Author Manuscript

Organ Donation- Donation after Cardiac Death—Organ donation after cardiac death
(DCD) and donation following brain death (death by neurological criteria [“DNC”]) are
important considerations for neurocritically ill patients. The opportunity to save lives
through organ donation can provide solace to some grieving families.[74, 82] Late or missed
referrals to the organ procurement organization (OPO) deprive the family and patient of the
opportunity to donate organs. In the United States, all hospitals are required to notify their
assigned OPO when specific criteria are met such as loss of brainstem reflexes in a patient
who may be approaching brain death, or consideration of withdrawal of life-sustaining
therapies. Early notification is essential to allow time for OPO determination of donor
suitability and for family decision-making. The decision to withdraw life-sustaining therapy
should be made independently of discussions regarding organ or tissue donation, and
withdrawal of life support should occur only after the family has had the opportunity to
make an informed decision.

Author Manuscript

Following consent for DCD, extubation occurs in the operating room. The family should be
offered the opportunity to be present and briefed on the organ recovery process, which
entails antiseptic measures including prepping and draping prior to extubation. An OPO
family counselor may be present in the operating room for additional family support.
Valuable input may also be provided by a palliative care specialist/team [83], a social
worker, and/or another clinician with appropriate training to support the family. DCD
involves the use of some therapies (such as intravenous fluids, intravenous heparin,
hemodynamic monitoring) that support the donation process.[74] To set appropriate
expectations, the family should be informed that not all patients are suitable donors. If
cardiopulmonary death does not occur after extubation (generally within an hour) and the
OPO decides that the patient is no longer a suitable donor, the patient will be returned to the
ICU or transition to a palliative care unit or other hospital bed for end-of-life care.[74]
Organ Donation: Death by Neurological Criteria—When brain death is expected and
imminent, the use of aggressive therapies (such as osmotic therapy) may be futile, and lead
to complications that can compromise organ donation. It is then reasonable to transition
from “brain protective” strategies of care to “organ protective” strategies. While this
approach still involves intensive medical management (e.g. treatment of hypotension,
diabetes insipidus), it allows time for families to come to terms with the concept of brain
death, and preserves organ homeostasis for possible donation.

Author Manuscript

Communicating the concept of death by neurologic criteria presents unique challenges as
this concept is not accepted in certain cultures or religions.[84] Concrete communication,
such as “brain death means the patient is declared dead,” is essential to avoid
misunderstanding. In circumstances in which brain death is not accepted by the family, it is
reasonable to continue mechanical ventilation for a limited time while supporting the family.
Eliminating blood draws, electrolyte correction and vasopressor use and allowing the patient
to progress to cardiopulmonary death may be necessary. When the patient/family has
consented to donation, medical management may involve invasive diagnostic procedures to
Crit Care Med. Author manuscript; available in PMC 2016 September 01.
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investigate donor suitability, and therapies aimed at restoring perfusion, such as hormonal
replacement, and vasopressor support.[82]. Families should be counseled as to these
possibilities by the OPO and supported throughout the donation process.

Author Manuscript
Author Manuscript

Time to death after palliative extubation—A common question raised by family
members is, when will death occur following extubation? It is important to describe to the
family what is likely to happen over the minutes, hours or days following extubation. For
example: “the patient may not be awake, and may make sounds similar to snoring. We
expect that the patient will drift into a deeper coma and not respond over the next few hours/
days. Eventually the breaths will get further apart until they stop and death comes
peacefully”. Expected timing of death is relevant in the context of DCD because cessation of
cardiopulmonary activity within 60 minutes of extubation is a requirement for DCD in most
states. In a multicenter study of comatose patients with irreversible brain injury undergoing
palliative extubation, 46% died within 60 minutes. Major predictors of death within 60
minutes included: absent corneal reflex, absent cough, extensor or absent motor response
and oxygenation index >3.0 (where oxygenation index= [FiO2 × mean airway pressure in
cmH2O/PaO2 in torr] × 100).[85] Table 5 shows the DCD-N scoring system to predict the
likelihood of cardiopulmonary arrest after withdrawal of life support. Other authors have
produced similar results using equivalent models.[86] ICU specialist opinion regarding the
probability of death within 60 minutes after withdrawal of life-sustaining therapy has been
found to be very accurate along with variables such as pH, Glasgow Coma Score,
spontaneous respiratory rate, PEEP level and systolic blood pressure.[87] Withdrawal of life
sustaining therapies does not necessarily lead to imminent death. In studies based on the
Nationwide Inpatient Sample, nearly 40% of patients with ischemic stroke who received
thrombolysis and nearly 20% of patients with subarachnoid hemorrhage who underwent
withdrawal of life support survived to hospital discharge. The discharge destination may be
a long-term care facility or hospice. Additionally, length of stay and mean hospital costs
were lower in patients who underwent withdrawal.[88, 89]

Conclusions
Neurocritically ill patients and their families have needs that require integration of palliative
care principles, practices, and services. Attention to the trajectory of neurocritical illness,
utility and limitations of neuro-prognostic tools, and the public perceptions of coma and
survival, can help inform effective communication and decision making. A shared, valuebased decision making model for establishing goals of care, and special consideration of
symptom management and family support during withdrawal of life-sustaining therapy can
help ensure the delivery of high-quality palliative care to neurocritically ill patients.
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Figure 1. Distinctive Trajectories of Neurocritical Illness
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This figure demonstrates trajectories for patients without limitation of life supporting
therapies. Onset of neurocritical illness is often sudden, with precipitous decline from a
normal baseline. However, most neurocritically ill patients do not progress to cardiovascular
death or brain death, but survive with disability.
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Figure 2. Shared Decision Making in Goals of Care Discussions

Author Manuscript

Both physicians and the patient/surrogate contribute to goals of care discussions. The
physician should consider how individual patient factors and published prognostic scales
contribute to the patient's overall prognosis. The patient/surrogate should contemplate the
patient's advance directive and value system to determine if the best estimated prognosis is
aligned with the patient's perception of an acceptable quality of life. Based on this balance, a
shared-decision for appropriate goals of care can be reached.
GCS=Glasgow Coma Score[17]; FOUR Score[90]; Marshall Head Injury Score[91];
IMPACT score[92]; CRASH score [93]; ICH=intracerebral hemorrhage; ICH Score[18];
FUNC Score[21]; SAH=subarachnoid hemorrhage; Hunt Hess grade[20]; WFNS=World
Federation of Neurosurgeons Score[94]; HAIR score[95]; ASIA= American Spinal Injury
Association Scale[96]
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Table 1
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Common Adult Neuro ICU Diagnoses and Outcomes
Condition

Incidence in U.S.
(annual)

Mortality Rates (%)
In-Hospital

30-Day

Functional Independence at
3-12 months (%)

Traumatic Brain Injury

2,500,000 [97]

7.5% [98]

21% [99]

*
25-32% [100-102]

Ischemic Stroke

795,000 [97]

4.3-70% [98, 103]

16-23%[104, 105]

50% [106-108]

Anoxic Brain Injury

424,000 out-of-hospital
cardiac arrests [109]

^
52-90% [98, 110]

25-40%

200,000 [113]

14-50% [114, 115]

19-65% [116-118]

42% [119]

Intracerebral Hemorrhage

63,000 [120]

30% [98]

34-50% [120-123]

12-39% [123]

Subarachnoid Hemorrhage

25,000 [124]

20-26% [98, 124-127]

45% [98, 124-127]

16-55% [128, 129]

^^

Status Epilepticus

**

[111, 112]

**

48-55%

[111, 112]

*

Among patients with severe traumatic brain injury

Author Manuscript

^

Overall 90% mortality including those who do not survive to hospital admission [109]

**

Among patients who underwent targeted temperature management. Mortality rates are higher and functional outcome worse in patients with
PEA/asystole arrest compared to Vfib/Vtach arrest.
^^
Patients with refractory status epilepticus (continued seizures after two anti-epileptic drugs have been administered) have higher mortality rates
and worse functional outcomes.
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Table 2

Author Manuscript

Conditions that are Predictive of Poor Neurological Outcome [16]
Neurological Insult

Author Manuscript

Features Predictive of Poor
Prognosis

Time frame of
outcome
measurement

Level of Evidence

Coma with loss of pontomesencephalic
brainstem reflexes [130]
Midline shift of the pineal gland >4
mm within 48 hours of onset [131]
Age >60 years [103, 132]

14 days-6 months

Prospective, observational and
randomized controlled trials

Cerebellar Ischemic Stroke

Coma after decompressive
neurosurgery[133]

3 months

Prospective, observational

Lobar Intracerebral Hemorrhage

Coma with extensor posturing and
absent pontomesencephalic brainstem
reflexes [134-137]
Coma with midline septum pellucidum
shift >6 mm within 48 hours of onset
[136]

1-15 months

Prospective and retrospective,
observational

Deep Basal Ganglion Intracerebral
Hemorrhage

Coma with hydrocephalus and bleed
volume > 60 mL [135, 138-142]

1-3 months

Prospective and retrospective,
observational

Pontine Hemorrhage

Coma with hyperthermia and
tachycardia
Coma with hemorrhage extension into
the midbrain or thalamus and acute
hydrocephalus[143, 144]

3-12 months

Retrospective, observational

Cerebellar Hemorrhage

Absent oculocephalic reflexes with
hydrocephalus
Absent corneal reflexes [145-147]

3 months

Retrospective, observational

Aneurysmal Subarachnoid Hemorrhage

Persistent deep coma or Hunt Hess
grade 5 after attempts to lower ICP
[129]

12 months

Prospective, observational

*

Hemispheric Ischemic Stroke

Author Manuscript

*
The risk of poor outcome in patients ≤60 years old with large hemispheric stroke is attenuated by decompressive hemicraniectomy. Mortality is
reduced from 71% to 22% with hemicraniectomy versus medical management (P<0.0001) and the chances of moderate disability (able to walk
without assistance or better) at 12 months was 43% with hemicraniectomy versus 21% without (P=0.014).[103]
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Table 3

Author Manuscript

Selected Prognostic Scales Commonly Used in Neurocritical Illness
Prognostic Scale

Scoring

Outcome Measure(s)

Pros and Cons

Traumatic Brain Injury

Glasgow Coma Scale[17]

3 (worst)-15 (best)

Mortality, functional outcome

Widely used and
simple, but the
verbal score
cannot be
assessed in
intubated
patients; and
brainstem
reflexes and
breathing
patterns are not
assessed as part
of the GCS.

FOUR Score[90]
(Full Outline of
Unresponsiveness)

0 (worst)- 16
(best)

In-hospital mortality

Has good intraand inter-rater
reliability and
distinguishes
among patients
with the lowest
GCS scores. Not
widely used, and
predicts only
mortality, not
functional
outcome.

Marshall Classification of Head
Injury on Head Computed
tomography[91]

I-VI

Intracranial Pressure,
functional outcome

Widely used and
has been found
to predict
increased
intracranial
pressure and
outcome, but
focuses primarily
on CT findings
and does not
incorporate exam
or other
prognostic
factors.

Hunt-Hess Grade[20]

I (best)-V (worst)

Mortality, functional outcome

Commonly used
in the U.S., the
Hunt-Hess grade
is one of the
strongest
predictors of
outcome after
subarachnoid
hemorrhage. It
does not
distinguish well
between
moderately
injured grade 3
patients.

World Federation of
Neurological Surgeons Scale[94]

1 (best)-5 (worst)

Mortality, functional outcome

Commonly used
in Canada and
Europe, WFNS
combines the
GCS score with
the presence or
absence of a
major
neurological
deficit. It is
similar to Hunt-

Author Manuscript

Condition

Author Manuscript

Subarachnoid Hemorrhage
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Condition

Prognostic Scale

Scoring

Outcome Measure(s)

Pros and Cons

Author Manuscript

Hess scale in
predicting
outcome.[148]
Does not
distinguish
outcome well
among grade III
patients and there
is variable
application of
what constitutes
a “major
neurological
deficit”.
Intracerebral Hemorrhage

Author Manuscript
Author Manuscript

Anoxic Brain Injury

Spinal Cord Injury

Author Manuscript

ICH Score[18]

0 (best)- 6 (worst)

Mortality

Widely used and
simple scoring
system. Focuses
on mortality only
and confounded
by withdrawal.
Not validated in
a separate cohort.

FUNC Score[21]

0 (worst)-11 (best)

Functional Outcome

Incorporates
premorbid
cognitive
function and
strongly predicts
long term
functional
outcome. In
multiple cohorts,
no patient with a
FUNC score ≤4
achieved
functional
independence,
while >80% of
patients with a
FUNC score of
11 were
functionally
independent at 3months. Not
widely used.

Poor outcome
predicted by:
Myoclonus status
epilepticus (24
hours)
Absent SSEP N20
bilaterally (24-72
hours)
NSE>33 μg/L
(24-72 hours)
Exam with absent
pupil or corneal
responses;
extensor or no
motor response
(72 hours)

Mortality, functional outcome

Provides a time
based guideline
for
prognostication
with low false
positive rates at
each step. Does
not account for
the improved
outcomes with
hypothermia/
induced
normothermia.
Guidelines are
nearly a decade
old.[149]

A (worst)- E (best)

Motor and Sensory Function

The ASIA scale
was not
originally
developed as a
prognostic scale,
but does
correlate with
functional
outcome. [96]

*

AAN prognostic guideline[149]

American Spinal Injury
Association Scale (ASIA)[96]
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ICH=intracerebral hemorrhage; AAN=American Academy of Neurology; SSEP=median somatosensory evoked potentials; NSE=neuronal specific
enolase
*

Applies to patients who have not undergone therapeutic hypothermia/induced normothermia.
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Table 4

Author Manuscript

Steps in Discussing Goals of Care [54, 150]

Author Manuscript

Step 1

Introduce

After ensuring a quiet setting where all participants can sit down, introduce the members of the
clinical team and their roles. Ask family to introduce themselves and their relationship to the
patient.

Step 2

Empathize

Express empathy and acknowledge that this is a difficult time and a challenging conversation. If
the family is too emotionally overwhelmed to absorb and use information, continue responding
empathically to the emotion before presenting information and decisions.

Step 3

Inquire, Inform, Process
Emotional Reactions

Inquire into the family's current understanding of the patient's condition. Clarify any gaps in
understanding and update the family. Use of brain images may be useful for receptive families.
Use of lay-person terminology is essential (e.g. “bleeding in the brain”, “dead brain tissue”).
Allow families time to absorb information and ask questions.

Step 4

Understand the patient's
values

Review advance care planning discussions and written advance directives, if available, with the
family, and seek out information about patient and family values that can guide decisionmaking.

Step 5

Present Prognosis

Present the medical team's assessment of the patient's most likely prognosis in terms of future
cognitive and functional outcome, acknowledging limitations and uncertainty in prognostication.
Acknowledge the resulting emotional reactions to this information.

Step 6

Present Broad Care Options

Offer possible pathways of care that are clearly delineated. In the right context, care focused
entirely on comfort should be presented as an alternative to continuation of intensive care
therapies. This approach may become more acceptable over a series of iterative discussions.

Step 7

Family Decision-Making

Given the clinician's best estimate of the patient's long-term cognitive/functional outcome, and
understanding the patient's values, ask the family to reflect on how the patient, if able, would
decide in the present circumstances. If the family is receptive, the clinician can offer a
professional recommendation based on best medical evidence and experience.

Step 8

Match Care Goals to Medical
Plan

Adjust the care plan to match goals including review of current interventions, medications, and
CPR/DNR status. Ask about specific goals of importance, such as living until an upcoming life
event, or returning to home rather than a facility.

Step 9

Reflection and Questions

Ask the family to summarize their understanding of the conversation. Reflect back what you
hear the family saying and summarize. Allow time for questions and offer the family time to
discuss and consider the options.

Step 10

Follow-up and Document

Make yourself available for follow-up conversations and questions. Document the results of the
meeting in the medical record. Discuss plans with team members not present for the meeting.
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Table 5

Author Manuscript

Prediction of Cardio-pulmonary Arrest After Withdrawal of Life Sustaining Therapy (DCD-N Score).[85]
Component

Score

Cough
    Present

0

    Absent

2

Corneal Reflex
    Present

0

    Absent

1

Motor response

Author Manuscript

    Flexor or better

0

    Extensor or absent

1

Oxygenation Index
    ≤3.0

0

    >3.0

1

Total Score

Death within 60 minutes

0

5%

1

27%

2

29%

3

52%

4

80%

5

89%

Author Manuscript

A score of ≥3 was associated with a 74% probability of death within 60 minutes, while a score of 0-2 was associated with a 77% probability of
survival beyond 60 minutes.
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